Michael G. Grey - 28 Apr 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
Director
Signature
/s/ Meghanne Downes, Attorney-in-Fact
Issuer symbol
HZNP
Transactions as of
28 Apr 2023
Transactions value $
$0
Form type
4
Filing time
02 May 2023, 19:17:15 UTC
Previous filing
02 Sep 2022
Next filing
04 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +3.91K +25.33% 19.4K 28 Apr 2023 Direct F1, F2
holding HZNP Ordinary Shares 48K 28 Apr 2023 By Davy Trust F3
holding HZNP Ordinary Shares 10K 28 Apr 2023 By Family Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units Options Exercise $0 -3.91K -100% $0.00* 0 28 Apr 2023 Ordinary Shares 3.91K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
F2 15,448 Ordinary Shares previously reported as held indirectly by the Davy Trust are held directly.
F3 Shares were previously reported as indirectly held by the Davy Trust and inadvertently understated by 8,105 shares on filings made after April 30, 2021.
F4 10,000 Ordinary Shares previously reported as indirectly held by the Davy Trust are indirectly held by the Family Trust.